Company Filing History:
2 out of 624 
1 out of 102 Years Active: 2017-2025
Title: Hyeon Young Kim: Innovator in Pharmaceutical Chemistry
Introduction
Hyeon Young Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating autoimmune diseases and tumors. With a total of 2 patents, his work showcases innovative approaches to addressing complex health issues.
Latest Patents
Hyeon Young Kim's latest patents include a tricyclic compound as an IRAK4 inhibitor. This invention relates to a pharmaceutical composition aimed at preventing or treating autoimmune diseases or tumors. The composition contains a tricyclic compound represented by a specific chemical formula or a pharmaceutically acceptable salt thereof. Additionally, he has developed a health food composition that utilizes the tricyclic compound as an active ingredient.
Another significant patent involves an 8-oxoprotoberberine derivative, which is also a pharmaceutically acceptable salt. This invention focuses on a preparation method and a pharmaceutical composition for preventing or treating diseases associated with the activity of NFAT5. The novel derivative has shown remarkable improvements in oral absorption compared to known protoberberine, making it a promising candidate for treating rheumatoid arthritis and inflammatory diseases.
Career Highlights
Hyeon Young Kim has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and the Catholic University of Korea Industry-Academic Cooperation Foundation. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Hyeon Young Kim has collaborated with notable colleagues, including Heeyeong Cho and Hee-Jong Lim. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Hyeon Young Kim's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical science. His work not only addresses pressing health challenges but also paves the way for future research and development in the field.